Paris—Global law firm Dentons advised French investment group Verdoso on the acquisition of the perfusion business, Carelide, from Macopharma Group, a global leader in infusion, transfusion and biotherapy systems.

Verdoso invests in companies facing operational challenges, which can benefit from its financial resources and entrepreneurial approach. It takes an active investment position, working with management to enhance performance.  Driven by an ambitious development plan, Verdoso is considering a strategic transformation program for Carelide.

A multi-disciplinary Dentons team, led by Olivia Guéguen, partner in M&A and Life Sciences, advised Verdoso on the transaction.

The core team included Anne-Laure Marcerou, partner in M&A and Life Sciences; Laura Godard, Jean-Etienne Moreau, Pierre-Marie Gallo, associates; Audrey Molina, partner in Restructuring; Katell Déniel-Allioux, partner in Employment; and Gianluca Calisti, partner in Tax.

About Dentons

Redefining possibilities. Together, everywhere. For more information visit dentons.com